<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1279">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04555187</url>
  </required_header>
  <id_info>
    <org_study_id>STUDY00021368</org_study_id>
    <nct_id>NCT04555187</nct_id>
  </id_info>
  <brief_title>Cardiovascular Risk Stratification in Covid-19</brief_title>
  <acronym>CaVaR-Co19</acronym>
  <official_title>Cardiovascular Risk Stratification in Covid-19</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oregon Health and Science University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Oregon Health and Science University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This retrospective double-cohort study seeks to:

        1. Describe the cardiovascular manifestations and electrophysiological (EP) substrate in
           COVID-19 infection and their association with clinical outcomes; and

        2. Develop a method of cardiovascular risk stratification in COVID-19
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">June 8, 2020</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number and rate of persons with cardiovascular composite outcome</measure>
    <time_frame>6 months after Covid19 test</time_frame>
    <description>Number and rate of persons with composite of all-cause death, critical care utilization (ICU bed), development of a life-threatening arrhythmia (ventricular tachycardia/ventricular fibrillation or sudden cardiac arrest), acute heart failure, myocardial infarction (STEMI, NSTEMI, or silent MI), or incident stroke, whichever comes first.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of all-cause death outcome</measure>
    <time_frame>6 months after covid19 test</time_frame>
    <description>Rate of all-cause death outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of cardiac arrhythmia</measure>
    <time_frame>6 months after covid19 test</time_frame>
    <description>Rate of any documented cardiac arrhythmia (tachy - or brady- arrhythmia)</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">60000</enrollment>
  <condition>Covid19</condition>
  <condition>Cardiovascular Risk Factor</condition>
  <arm_group>
    <arm_group_label>Covid19-positive</arm_group_label>
    <description>Covid19 test positive. age &gt;= 18 y.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Covid19-negative</arm_group_label>
    <description>Covid19 test negative. age &gt;=18y</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Records of patients who had Covid19 test performed
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age &gt;=18y

          -  available data on Covid19 test in the electronic medical record (either positive or
             negative)

        Exclusion Criteria:

          -  no data of Covid19 test
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Larisa G Tereshchenko, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Oregon Health and Science University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Oregon Health and Science University</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>September 16, 2020</study_first_submitted>
  <study_first_submitted_qc>September 16, 2020</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 18, 2020</study_first_posted>
  <last_update_submitted>September 17, 2020</last_update_submitted>
  <last_update_submitted_qc>September 17, 2020</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 21, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Oregon Health and Science University</investigator_affiliation>
    <investigator_full_name>Larisa Tereshchenko</investigator_full_name>
    <investigator_title>Associate Professor of Medicine</investigator_title>
  </responsible_party>
  <keyword>Covid19</keyword>
  <keyword>cardiovascular risk factor</keyword>
  <keyword>electrocardiogram</keyword>
  <keyword>risk stratification</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

